June 25, 2017 6:44 AM ET

Biotechnology

Company Overview of Feldan Bio Inc.

Company Overview

Feldan Bio Inc., a recombinant protein company, discovers, develops, manufactures, and markets recombinant proteins and molecular biology reagents for life science companies and research laboratories in the United States, Canada, Europe, and internationally. The company develops Feldan Shuttle, a protein-based technology platform that delivers transcription factors and genome editing tools in clinical applications. It also provides Anti-AFP, a mouse monoclonal antibody; B-Cell culture supplement; FastFect, a transfection reagent; Hybridoma cloning booster; Hybridoma fusion and cloning booster; Hybridoma fusion booster; recombinant fibroblast growth factor-2; recombinant human epidermal growt...

4975 Rideau Street

Suite 100

Industrial Park

Quebec, QC G2E 5H5

Canada

Founded in 1999

Phone:

418-872-7277

Fax:

418-872-7007

Key Executives for Feldan Bio Inc.

Co-Founder, Chief Executive Officer and Director
Production Director
Research Director
Director of Development
Compensation as of Fiscal Year 2016.

Feldan Bio Inc. Key Developments

Feldan Therapeutics and Elasmogen Announce Research Agreement with Amgen to Develop Intracellular Biologics

Elasmogen Ltd. and Feldan Therapeutics announce a research collaboration with Amgen, to develop and deliver novel intracellular biologics. The collaboration combines the unique capabilities of Feldan's Shuttle platform and Elasmogen's soloMER™ technology to develop the delivery system and binding domains to two undisclosed intracellular targets for Amgen. The Feldan Shuttle technology is a novel peptide-based delivery method that enables the highly efficient introduction of foreign proteins into cells. Elasmogen's soloMER's are the smallest naturally occurring binding domains. Their small size and robust nature, particularly the resistance to changes in pH and ability to bind in intracellular conditions makes them the perfect complement to Feldan's technology.

Feldan Therapeutics Presents at 9th Annual Conference Biotech Showcase, Jan-09-2017

Feldan Therapeutics Presents at 9th Annual Conference Biotech Showcase, Jan-09-2017 . Venue: HILTON SAN FRANCISCO UNION SQUARE, 333 O'Farrell Street, San Francisco, CA 94102, United States.

Feldan Bio Inc. Presents at Redefining Early Stage Investments (RESI) Conference 2016, Jan-12-2016

Feldan Bio Inc. Presents at Redefining Early Stage Investments (RESI) Conference 2016, Jan-12-2016 . Venue: Marine's Memorial Club & Hotel, 609 Sutter St, San Francisco, CA 94102, United States.

Similar Private Companies By Industry

Company Name Region
2007262 Ontario, Inc. Americas
2056273 Ontario, Inc. Americas
AB BioPharma Inc. Americas
AbCelex Technologies Inc. Americas
AbCellera Biologics Inc. Americas

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
The Advertising Council, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Feldan Bio Inc., please visit www.feldan.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.